Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $1.93 Million - $2.35 Million
-11,800 Reduced 98.33%
200 $39,000
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $928,740 - $1.08 Million
-6,000 Reduced 33.33%
12,000 $2.06 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $14.7 Million - $16.7 Million
-91,900 Reduced 83.62%
18,000 $3.28 Million
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $96,320 - $108,479
-700 Reduced 0.63%
109,900 $17 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $4.98 Million - $5.77 Million
37,300 Added 50.89%
110,600 $16.5 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $5.49 Million - $6.83 Million
-41,400 Reduced 36.09%
73,300 $9.88 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $12.5 Million - $14.4 Million
86,700 Added 309.64%
114,700 $18.3 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $3.8 Million - $4.56 Million
27,500 Added 5500.0%
28,000 $4.53 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $67,105 - $76,965
500 New
500 $67,000
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $3.88 Million - $4.59 Million
-43,200 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $3.05 Million - $4.09 Million
33,200 Added 332.0%
43,200 $4.09 Million
Q2 2017

Aug 14, 2017

BUY
N/A
10,000
10,000 $725,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.